High prevalence of undiagnosed impaired glucose tolerance in patients with rheumatoid arthritis
- PMID: 35356811
- PMCID: PMC8958710
- DOI: 10.1177/20503121221088088
High prevalence of undiagnosed impaired glucose tolerance in patients with rheumatoid arthritis
Abstract
Objectives: Although the risk of diabetes mellitus has been recognised in rheumatoid arthritis, undiagnosed dysglycaemia remained under-reported. The study aimed to determine the prevalence and associated factors of dysglycaemia among patients with rheumatoid arthritis, utilising the oral glucose tolerance test.
Methods: This cross-sectional study involved patients with rheumatoid arthritis, aged ⩾30 years. Following an oral glucose tolerance test, they were divided into two: dysglycaemia and normoglycaemia. Demographic and laboratory parameters were compared using logistic regression analyses.
Results: There were 35.5% (55/155) patients with dysglycaemia (including 25.8% impaired glucose tolerance, 7.1% diabetes mellitus and 1.9% with both impaired fasting glucose and impaired glucose tolerance). Patients with dysglycaemia were heavier (65.5 ± 12.3 versus 60.7 ± 10.6 kg, p = 0.01), had wider waist (89.0 ± 12.5 versus 83.1 ± 9.6 cm, p < 0.01), lower high-density lipoprotein cholesterol (1.4 ± 0.3 versus 1.5 ± 0.4 mmol/L, p = 0.02), higher triglyceride (1.3 (0.9-1.8) versus 0.9 (0.8-1.2) mmol/L, p < 0.01) and intercellular adhesion molecule-1 (361.79 (290.38-481.84) versus 315.92 (251.45-407.93) ng/mL, p = 0.01). History of smoking (odds ratio: 5.70, confidence interval: 1.27-25.7), elevated triglyceride (odds ratio: 2.87, confidence interval: 1.33-6.22) and intercellular adhesion molecule-1 (odds ratio: 1.003, confidence interval: 1.001-1.006) were significantly associated with dysglycaemia.
Conclusions: Prevalence of undiagnosed dysglycaemia, particularly impaired glucose tolerance, was high in these patients with rheumatoid arthritis, using a 75-g oral glucose tolerance test, which was not associated with disease activity or corticosteroid use. Those with high triglyceride, history of smoking and elevated intercellular adhesion molecule-1 were the two significant predictors for dysglycaemia in our patients with rheumatoid arthritis. Oral glucose tolerance test could be an important laboratory investigation for dysglycaemia in these high-risk patients.
Keywords: Rheumatoid arthritis; dysglycaemia; impaired glucose tolerance; oral glucose tolerance test; type 2 diabetes mellitus.
© The Author(s) 2022.
Conflict of interest statement
Declaration of conflicting interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship and/or publication of this article.
Figures
References
-
- Plenge RM. Rheumatoid arthritis genetics: 2009 update. Curr Rheumatol Rep 2009; 11(5): 351–356. - PubMed
-
- Cross M, Smith E, Hoy D, et al.. The global burden of rheumatoid arthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis 2014; 73(7): 1316–1322. - PubMed
-
- Rosman A, Hussein H, Chyn GS, et al.. National Inflammatory Arthritis Registry (NIAR). National Inflammatory Arthritis Registry (NIAR) Preliminary Report (2009-2010), 2012, https://www.crc.gov.my/wp-content/uploads/documents/report/NIAR_Report.pdf
-
- Rosman M. Zain M, Ch’ng SS, et al.. NIAR and MARBLE rheumatoid arthritis. Malaysian National Inflammatory Arthritis Registry, Ministry of Health Malaysia, 2019, https://www.moh.gov.my/moh/resources/Penerbitan/CPG/2)_CPG_Management_of...
LinkOut - more resources
Full Text Sources